Taking too long? Close loading screen.
Connect with us


Found: genes that sway the course of the coronavirus



Science‘s COVID-19 coverage is supported by the Pulitzer Center.

It’s one of the pandemic’s puzzles: Most people infected by SARS-CoV-2 never feel sick, whereas others develop serious symptoms or even end up in an intensive care unit clinging to life. Age and preexisting conditions, such as obesity, account for much of the disparity. But geneticists have raced to see whether a person’s DNA also explains why some get hit hard by the coronavirus, and they have uncovered tantalizing leads.

Now, a U.K. group studying more than 2200 COVID-19 patients has pinned down common gene variants that are linked to the most severe cases of the disease, and that point to existing drugs that could be repurposed to help. “It’s really exciting. Each one provides a potential target” for treatment, says genetic epidemiologist Priya Duggal of Johns Hopkins University.

Kenneth Baillie of the University of Edinburgh, an intensive care physician and geneticist, led the new study, which he discussed on 2 October at an online meeting of a data-pooling effort called the COVID-19 Host Genetics Initiative. He’s hoping the results, also posted as a preprint on medRxiv, will speed treatments, although he cautions that any clinical trial inspired by the findings should wait for the study’s acceptance in a peer-reviewed journal. “Because the epidemic is progressing at such an alarming rate, even a few months of time saved will save lots of lives,” Baillie says.

Embedded ImageEmbedded Image

A study of some of the sickest COVID-19 patients, such as those placed on ventilators, has identified gene variants that put people at greater risk of severe disease.


In a standard approach to finding genes that influence a condition, geneticists scan the DNA of large numbers of people for millions of marker sequences, looking for associations between specific markers and cases of the disease. In June, one such genome-wide association study in The New England Journal of Medicine (NEJM) found two “hits” linked to respiratory failure in 1600 Italian and Spanish COVID-19 patients: a marker within the ABO gene, which determines a person’s blood type, and a stretch of chromosome 3 that holds a half-dozen genes. Those two links have also emerged in other groups’ data, including some from the DNA testing company 23andMe.

The new study confirmed the chromosome 3 region’s involvement. And because 74% of its patients were so sick that they needed invasive ventilation, it had the statistical strength to reveal other markers, elsewhere in the genome, linked to severe COVID-19. One find is a gene called IFNAR2 that codes for a cell receptor for interferon, a powerful molecular messenger that rallies the immune defenses when a virus invades a cell. A variant of IFNAR2 found in one in four Europeans raised the risk of severe COVID-19 by 30%. Baillie says the IFNAR2 hit is “entirely complementary” to a finding reported in Science last month: Very rare mutations that disable IFNAR2 and seven other interferon genes may explain about 4% of severe COVID-19 cases (25 September, p. 155). Both studies raise hopes for ongoing trials of interferons as a COVID-19 treatment.

A more surprising hit from the U.K. study points to OAS genes, which code for proteins that activate an enzyme that breaks down viral RNA. A change in one of those genes might impair this activation, allowing the virus to flourish. The U.K. data suggest there is a variant as common and influential on COVID-19 as the interferon genetic risk factor.

Other genes identified by Baillie’s team could ramp up the inflammatory responses to lung damage triggered by SARS-CoV-2, reactions that can be lethal to some patients. One, DPP9, codes for an enzyme known to be involved in lung disease; another, TYK2, encodes a signaling protein involved in inflammation. Drugs that target those two genes’ proteins are already in use—inhibitors of DPP9‘s enzyme for diabetes and baricitinib, which blocks TYK2‘s product, for arthritis. Baricitinib is in early clinical testing for COVID-19, and the new data could push it up the priority list, Baillie says.

The chromosome 3 region still stands out as the most powerful genetic actor: A single copy of the disease-associated variant more than doubles an infected person’s odds of developing severe COVID-19. Evolutionary biologists reported last month in Nature that this suspicious region actually came from Neanderthals, through interbreeding with our species tens of thousands of years ago. It is now found in about 16% of Europeans and 50% of South Asians.

But the specific chromosome 3 gene or genes at play remain elusive. By analyzing gene activity data from normal lung tissue of people with and without the variant, the U.K. team homed in on CCR2, a gene that encodes a receptor for cytokine proteins that play a role in inflammation. But other data discussed at last week’s meeting point to SLC6Z20, which codes for a protein that interacts with the main cell receptor used by SARS-CoV-2 to enter cells. “I don’t think anyone at this point has a clear understanding of what are the underlying genes” for the chromosome 3 link, says Andrea Ganna of the University of Helsinki, who co-leads the COVID-19 Host Genetics Initiative.

The U.K. genetics study did not confirm that the ABO variants affect the odds of severe disease. Some studies looking directly at blood type, not genetic markers, have reported that type O blood protects against COVID-19, whereas A blood makes a person more vulnerable. It may be that blood type influences whether a person gets infected, but not how sick they get, says Stanford University geneticist Manuel Rivas. In any case, O blood offers at best modest protection. “There are a lot of people with O blood that have died of the disease. It doesn’t really help you,” says geneticist Andre Franke of the Christian-Albrecht University of Kiel, a co-leader of the NEJM study.

Researchers expect to pin down more COVID-19 risk genes—already, after folding in the U.K. data plumbed by Baillie’s team, the COVID-19 Host Genetics Initiative has found another hit, a gene called FOXP4 implicated in lung cancer. And in a new med-Rxiv preprint posted last week, the company Ancestry.com reports that a gene previously connected to the effects of the flu may also boost COVID-19 susceptibility only in men, who are more likely to die of the disease than women.

Geneticists have had little luck so far identifying gene variants that explain why COVID-19 has hit Black people in the United States and United Kingdom particularly hard. The chromosome 3 variant is absent in most people of African ancestry. Researchers suspect that socioeconomic factors and preexisting conditions may better explain the increased risks. But several projects, including Baillie’s, are recruiting more people of non-European backgrounds to bolster their power to find COVID-19 gene links. And in an abstract for an online talk later this month at the American Society of Human Genetics annual meeting, the company Regeneron reports it has found a genome region that may raise the risk of severe disease mainly in people of African ancestry.

Even as more genetic risk factors are identified, their overall effect on infected people will be modest compared with other COVID-19 factors, Duggal says. But studies like the U.K. team’s could help reveal the underlying biology of the disease and inspire better treatments. “I don’t think genetics will lead us out of this. I think genetics may give us new opportunities,” Duggal says.


Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


SpaceX launches Starlink app and provides pricing and service info to early beta testers



SpaceX has debuted an official app for its Starlink satellite broadband internet service, for both iOS and Android devices. The Starlink app allows users to manage their connection – but to take part you’ll have to be part of the official beta program, and the initial public rollout of that is only just about to begin, according to emails SpaceX sent to potential beta testers this week.

The Starlink app provides guidance on how to install the Starlink receiver dish, as well as connection status (including signal quality), a device overview for seeing what’s connected to your network, and a speed test tool. It’s similar to other mobile apps for managing home wifi connections and routers. Meanwhile, the emails to potential testers that CNBC obtained detail what users can expect in terms of pricing, speeds and latency.

The initial Starlink public beta test is called the “Better than Nothing Beta Program,” SpaceX confirms in their app description, and will be rolled out across the U.S. and Canada before the end of the year – which matches up with earlier stated timelines. As per the name, SpaceX is hoping to set expectations for early customers, with speeds users can expect ranging from between 50Mb/s to 150Mb/s, and latency of 20ms to 40ms according to the customer emails, with some periods including no connectivity at all. Even with expectations set low, if those values prove accurate, it should be a big improvement for users in some hard-to-reach areas where service is currently costly, unreliable and operating at roughly dial-up equivalent speeds.

Image Credits: SpaceX

In terms of pricing, SpaceX says in the emails that the cost for participants in this beta program will be $99 per moth, plus a one-time cost of $499 initially to pay for the hardware, which includes the mounting kit and receiver dish, as well as a router with wifi networking capabilities.

The goal eventually is offer reliably, low-latency broadband that provides consistent connection by handing off connectivity between a large constellation of small satellites circling the globe in low Earth orbit. Already, SpaceX has nearly 1,000 of those launched, but it hopes to launch many thousands more before it reaches global coverage and offers general availability of its services.

SpaceX has already announced some initial commercial partnerships and pilot programs for Starlink, too, including a team-up with Microsoft to connect that company’s mobile Azure data centers, and a project with an East Texas school board to connect the local community.


Continue Reading


Erratum for the Report “Meta-analysis reveals declines in terrestrial but increases in freshwater insect abundances” by R. Van Klink, D. E. Bowler, K. B. Gongalsky, A. B. Swengel, A. Gentile, J. M. Chase



S. Rennie, J. Adamson, R. Anderson, C. Andrews, J. Bater, N. Bayfield, K. Beaton, D. Beaumont, S. Benham, V. Bowmaker, C. Britt, R. Brooker, D. Brooks, J. Brunt, G. Common, R. Cooper, S. Corbett, N. Critchley, P. Dennis, J. Dick, B. Dodd, N. Dodd, N. Donovan, J. Easter, M. Flexen, A. Gardiner, D. Hamilton, P. Hargreaves, M. Hatton-Ellis, M. Howe, J. Kahl, M. Lane, S. Langan, D. Lloyd, B. McCarney, Y. McElarney, C. McKenna, S. McMillan, F. Milne, L. Milne, M. Morecroft, M. Murphy, A. Nelson, H. Nicholson, D. Pallett, D. Parry, I. Pearce, G. Pozsgai, A. Riley, R. Rose, S. Schafer, T. Scott, L. Sherrin, C. Shortall, R. Smith, P. Smith, R. Tait, C. Taylor, M. Taylor, M. Thurlow, A. Turner, K. Tyson, H. Watson, M. Whittaker, I. Woiwod, C. Wood, UK Environmental Change Network (ECN) Moth Data: 1992-2015, NERC Environmental Information Data Centre (2018); .


Continue Reading


Max Q: NASA makes key discovery for future of deep space exploration



Max Q is a weekly newsletter from TechCrunch all about space. Sign up here to receive it weekly on Sundays in your inbox.

This past week, we unveiled the agenda for TC Sessions: Space for the first time. It’s our inaugural event focused on space startups and related technologies, and it’s happening December 16 and 17. It’s entirely virtual, of course, and the good news is that means you can attend easily from anywhere in the world.

We’ve got an amazing lineup, including newsmakers we regularly cover here. NASA Administrator Jim Bridenstine will be there, as well as U.S. Space Force commanding office Jay Raymond, and Rocket Lab CEO Peter Beck, to name just a few. Tickets are available now, so sign up ASAP to get the best price possible.

SpaceX launched not one, but two separate Falcon 9 rockets loaded with Starlink satellites for its broadband internet service last week. The first took off on October 19, then just five days later, another full complement reached orbit. SpaceX has now launched nearly 1,000 of these, and it must be getting awfully close to kicking off its public beta of the consumer-facing internet service.

OSIRIS-REx probe 'tagging' the surface of asteroid Bennu

Image Credits: NASA

NASA has managed to collect a sample from the surface of an asteroid in a first for the agency. The sample collection came courtesy of NASA’s OSIRIS-REx robotic exploration probe, which was built by partner Lockheed Martin. OSIRIS-REx still has some work to do at Bennu, the asteroid from which it collected the sample, but next year it’ll begin heading back with its precious cargo intended for study by scientists here on Earth.

NASA is full of special discoveries this week – scientists working on its SOFIA imaging project confirmed the presence of water on the surface of the Moon that’s exposed to sunlight. They’d suspected it was there previously, but this is the first confirmed proof, and while it isn’t a whole lot of water, it could still change the future of human deep space exploration.

Image Credits: Microsoft

Microsoft looks primed to invest in space-based business in a big way with Azure Space, a new business unit it formed to handle all space-related businesses attached to its cloud data efforts. That includes a new type of deployable mobile datacenter that will be connected in part via SpaceX’s Starlink global broadband network, putting computing power near where it’s needed in a scalable way.

Intel has loaded up a small satellite with a power-efficient edge AI processor, its Myriad 2 Vision Processing Unit. That’ll help the satellite do its own on-board classification of images of Earth that it takes, saving key bandwidth for what it transfers back to researchers on the ground. Local AI could help satellite networks in general operate much more efficiently, but it’s still in its infancy as a field.

Image Credits: Relativity Space

Relativity Space has tons of promise in terms of its 3D-printed rockets, but it still hasn’t actually reached the launch stage. It did however secure a key government contract, with Lockheed Martin selecting its rocket for a forthcoming mission to test fluid management systems for NASA.


Continue Reading